Navitas Semiconductor’s year-to-date stock performance.
Navitas Semiconductor: “That company’s losing a lot of money.”
Regeneron Pharmaceuticals’ year-to-date stock performance.
Regeneron Pharmaceuticals: “Regeneron’s a quandary. I’ve got to tell you, I expected sales to be better…I do prefer Eli Lilly.”
LandBridge’s year-to-date stock performance.
LandBridge: “That’s a winner. I would just hold on to it.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Disclaimer The CNBC Investing Club Charitable Trust holds shares of Eli Lilly.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? [email protected]